Please login to the form below
Pay-for-delay deals lead to inflated drug prices says study
Based on analysis of delayed market entry of generic Adderall XR in US
Celgene wins expanded EU approval for cancer drug Revlimid
Approved for use in patients with rare blood disorder
AbbVie: UK patients want better arthritis care
Study from Humira manufacturer concludes that UK doctors need better collaboration with patients
Alexion begins work on new global headquarters
Rare diseases drug company will move to new US site in 2015
AstraZeneca picks location for global HQ and research base
Decides on the Cambridge Biomedical Campus in UK
Think positive: the rise of 'smart drugs'
More and more people are turning to nootropics or 'smart drugs' to enhance their cognitive ability. But what do they do, what are the risks and where do the ethical
The future of HTA harmonisation in Europe
The variety and variability of European health technology assessment criteria have created a challenging environment for pharma and a need for much greater harmonisation
Google 'aiding and abetting' illegal online pharmacies
US state attorney general takes issue with auto-complete and ad policies
Former UK health secretary joins Bupa board
Patricia Hewitt will serve private health firm as non-executive director
The hunted now hunt: biotechs become buyers
As investor interest in biotech grows, larger companies are competing with pharma to acquire smaller firms
Former Novartis president joins Qu Biologics
Robert Pelzer is appointed board member at immunotherapy specialists
Why does the global data warehouse approach not work?
Webinar on how to align business intelligence globally and deploy it locally
PatientsLikeMe signs clinical trial deal with inVentiv
Online patient network aims to help the CRO accelerate trial recruitment
Featured jobs
- Head of Commercial Training Strategy (m/ f)
- On application
- Marketing Manager - Pharmaceuticals, Northern UK
- Excellent Salary & Benefits
- UK Marketing Director
- 80,000 to 100,000 per annum
- Medical Writer / Editor – LONDON
- DOE
Subscribe to our email news alerts
- Building BRICs: pharma's key emerging markets are becoming giants
- The hunted now hunt: biotechs become buyers
- Kantar Media and Pointlogic unveil comms planning platform
- AbbVie: UK patients want better arthritis care
- Pay-for-delay deals lead to inflated drug prices says study
- Google 'aiding and abetting' illegal online pharmacies
PMHub
Add my companyVivactis Global Health
Vivactis Global Health - In tune with your needs Vivactis Global Health is a newly formed medical communications agency. We ...
Latest intelligence
- Building BRICs: pharma's key emerging markets are becoming giants
- The BRIC nations – Brazil, Russia, India and China – for so long the leading lights of the emerging markets movement, may soon need to relinquish their 'emerging' tag and become 'giants'...
- What IF (Indigenus Forum) Meeting Report
- IFs (Indigenus Forums) are a series of invite-only events hosted by Indigenus agencies that bring top thought leaders together to help solve some of our industry’s most pressing challenges. ...
- Developing multichannel capability in Pharma
- Understanding your customers' needs is only half of the multichannel challenge; you must also have the business capability to deliver on your objectives. Find out how training could give your ...
Quick links
